Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions - Activation of vascular endothelial growth factor A

被引:195
|
作者
Liu, PQ [1 ]
Rebar, EJ [1 ]
Zhang, L [1 ]
Liu, Q [1 ]
Jamieson, AC [1 ]
Liang, YX [1 ]
Qi, H [1 ]
Li, PX [1 ]
Chen, BL [1 ]
Mendel, MC [1 ]
Zhong, XH [1 ]
Lee, YL [1 ]
Eisenberg, SP [1 ]
Spratt, SK [1 ]
Case, CC [1 ]
Wolffe, AP [1 ]
机构
[1] Sangamo BioSci Inc, Point Richmond Tech Ctr, Richmond, CA 94804 USA
关键词
D O I
10.1074/jbc.M011172200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have mapped conserved regions of enhanced DNase I accessibility within the endogenous chromosomal locus of vascular endothelial growth factor A (VEGF-A). Synthetic zinc finger protein (ZFP) transcription factors were designed to target DNA sequences contained within the DNase I-hypersensitive regions. These ZFPs, when fused to either VP16 or p65 transcriptional activation domains, were able to activate expression of the VEGF-A gene as assayed by mRNA accumulation and VEGF-A protein secretion through a range exceeding that induced by hypoxic stress. Importantly, multiple splice variants of VEGF-A mRNA with defined physiological functions were induced by a single engineered ZFP transcription factor. We present evidence for an enhanced activation of VEGF-A gene transcription by ZFP transcription factors fused to VP16 and p65 targeted to two distinct chromosomal sites >500 base pairs upstream or downstream of the transcription start site. Our strategy provides a novel approach for dissecting the requirements for gene regulation at a distance without altering the DNA sequence of the endogenous target locus.
引用
收藏
页码:11323 / 11334
页数:12
相关论文
共 10 条
  • [1] Robust activation of vascular endothelial growth factor a using designed zinc finger protein transcription factors
    Rebar, EJ
    Zhang, L
    Dent, C
    Lee, YL
    Liang, YX
    Hinh, L
    Johnstone, B
    Xu, L
    Liu, PQ
    Li, XY
    Schaal, TD
    Zhong, XH
    Spratt, SK
    Rokovich, J
    Case, CC
    Pabo, CO
    MOLECULAR THERAPY, 2003, 7 (05) : S461 - S461
  • [2] Induction of angiogenesis in rat skeletal muscle using a designed zinc finger protein transcriptional activator targeted to vascular endothelial growth factor A (VEGF-A)
    Johnstone, B
    Venstrom, K
    Zhang, L
    Xia, D
    Xu, L
    Antone, S
    Jouvenot, Y
    Schaal, T
    Lee, YL
    Liang, YX
    Spratt, K
    Rebar, E
    Olin, J
    Case, C
    Pabo, C
    Rokovich, J
    MOLECULAR THERAPY, 2003, 7 (05) : S235 - S235
  • [3] Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors
    Snowden, AW
    Zhang, L
    Urnov, F
    Dent, C
    Jouvenot, Y
    Zhong, XH
    Rebar, EJ
    Jamieson, AC
    Zhang, HS
    Tan, SY
    Case, CC
    Pabo, CO
    Wolffe, AP
    Gregory, PD
    CANCER RESEARCH, 2003, 63 (24) : 8968 - 8976
  • [4] Repression of Vascular Endothelial Growth Factor-A over-expression in glioblastoma cells using engineered zinc-finger transcription factors
    Snowden, AW
    Zhang, L
    Urnov, F
    Dent, C
    McNamara, AR
    Jouvenot, Y
    Zhang, SH
    Rebar, EJ
    Jamieson, AC
    Case, CC
    Gregory, PD
    MOLECULAR THERAPY, 2004, 9 : S245 - S245
  • [5] Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic controlTranscription of vascular endothelial growth factor receptor 3
    Johannes Hertel
    Christoph Hirche
    Christoph Wissmann
    Matthias P. Ebert
    Michael Höcker
    Cellular Oncology, 2014, 37 : 131 - 145
  • [6] Evidence of neuroregeneration using vascular endothelial growth factor zinc finger protein activator (SB-509) in diabetic neuropathy: a chronic degenerative polyneuropathy
    Ando, D. G.
    Merren, M.
    Douglas, N.
    Hamilton, S.
    Lee, Y. -L.
    Spratt, K.
    Benaim, E.
    Kipnes, M.
    DIABETOLOGIA, 2008, 51 : S504 - S504
  • [7] Evidence of neuroregeneration using vascular endothelial growth factor zinc finger protein activator (SB-509) in diabetic neuropathy: A chronic degenerative polyneuropathy
    Kipnes, Mark
    Merren, Michael
    Douglas, Warren
    Hamilton, Scott
    Lee, Ya-Li
    Spratt, S. Kaye
    Benaim, Ely
    Ando, Dale
    DIABETES, 2008, 57 : A68 - A68
  • [8] EVIDENCE OF NEUROREGENERATION USING VASCULAR ENDOTHELIAL GROWTH FACTOR ZINC FINGER PROTEIN ACTIVATOR (SB-509) IN DIABETIC NEUROPATHY: A CHRONIC DEGENERATIVE POLYNEUROPATHY
    Ando, Dale
    Hamilton, Scott
    Lee, Ya-Li
    Spratt, Kaye
    Benaim, Ely
    JOURNAL OF GENE MEDICINE, 2009, 11 (12) : 1139 - 1139
  • [9] Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control
    Hertel, Johannes
    Hirche, Christoph
    Wissmann, Christoph
    Ebert, Matthias P.
    Hoecker, Michael
    CELLULAR ONCOLOGY, 2014, 37 (02) : 131 - 145
  • [10] Reappearance of Nerve Potentials in Severe Diabetic Peripheral Neuropathy Patients with Unmeasurable Nerve Conduction Using Vascular Endothelial Growth Factor Zinc Finger Protein Activator (SB-509): Interim Phase 2 Results (SB-509-0701 Study)
    Benaim, Ely
    Hamilton, Scott
    Spratt, Kaye
    Giedlin, Marty
    Kim, Heidi
    Ando, Dale
    DIABETES, 2009, 58 : A64 - A64